X-48823531-A-G

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_006044.4(HDAC6):​c.3132A>G​(p.Ile1044Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000604 in 1,208,169 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 237 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00026 ( 0 hom., 7 hem., cov: 22)
Exomes š‘“: 0.00064 ( 0 hom. 230 hem. )

Consequence

HDAC6
NM_006044.4 missense

Scores

1
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 0.0900

Publications

0 publications found
Variant links:
Genes affected
HDAC6 (HGNC:14064): (histone deacetylase 6) Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene belongs to class II of the histone deacetylase/acuc/apha family. It contains an internal duplication of two catalytic domains which appear to function independently of each other. This protein possesses histone deacetylase activity and represses transcription. [provided by RefSeq, Jul 2008]
HDAC6 Gene-Disease associations (from GenCC):
  • X-linked dominant chondrodysplasia, Chassaing-Lacombe type
    Inheritance: XL Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03717178).
BP6
Variant X-48823531-A-G is Benign according to our data. Variant chrX-48823531-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 445380.
BS2
High Hemizygotes in GnomAd4 at 7 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HDAC6NM_006044.4 linkc.3132A>G p.Ile1044Met missense_variant Exon 25 of 29 ENST00000334136.11 NP_006035.2 Q9UBN7-1A0A024QZ26Q9NSW6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HDAC6ENST00000334136.11 linkc.3132A>G p.Ile1044Met missense_variant Exon 25 of 29 1 NM_006044.4 ENSP00000334061.5 Q9UBN7-1

Frequencies

GnomAD3 genomes
AF:
0.000261
AC:
29
AN:
111313
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0000980
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000381
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000416
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000297
AC:
53
AN:
178710
AF XY:
0.000219
show subpopulations
Gnomad AFR exome
AF:
0.000237
Gnomad AMR exome
AF:
0.0000367
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000593
Gnomad OTH exome
AF:
0.000452
GnomAD4 exome
AF:
0.000639
AC:
701
AN:
1096856
Hom.:
0
Cov.:
32
AF XY:
0.000635
AC XY:
230
AN XY:
362284
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26377
American (AMR)
AF:
0.000114
AC:
4
AN:
35148
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19336
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30169
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53863
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40374
Middle Eastern (MID)
AF:
0.00145
AC:
6
AN:
4135
European-Non Finnish (NFE)
AF:
0.000782
AC:
658
AN:
841414
Other (OTH)
AF:
0.000695
AC:
32
AN:
46040
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
27
54
80
107
134
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000261
AC:
29
AN:
111313
Hom.:
0
Cov.:
22
AF XY:
0.000209
AC XY:
7
AN XY:
33499
show subpopulations
African (AFR)
AF:
0.0000980
AC:
3
AN:
30606
American (AMR)
AF:
0.000381
AC:
4
AN:
10486
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2635
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3533
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2615
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6084
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
238
European-Non Finnish (NFE)
AF:
0.000416
AC:
22
AN:
52929
Other (OTH)
AF:
0.00
AC:
0
AN:
1506
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.520
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000391
Hom.:
2
Bravo
AF:
0.000280
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.000346
AC:
1
ESP6500AA
AF:
0.000261
AC:
1
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.000264
AC:
32

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 07, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 25, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Jun 26, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.3132A>G (p.I1044M) alteration is located in exon 25 (coding exon 24) of the HDAC6 gene. This alteration results from a A to G substitution at nucleotide position 3132, causing the isoleucine (I) at amino acid position 1044 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
4.4
DANN
Benign
0.95
DEOGEN2
Benign
0.11
T;T;T;T;T;.
FATHMM_MKL
Benign
0.063
N
LIST_S2
Benign
0.73
.;.;.;.;T;T
M_CAP
Benign
0.013
T
MetaRNN
Benign
0.037
T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.8
L;L;L;L;L;.
PhyloP100
0.090
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.42
N;.;N;.;.;.
REVEL
Benign
0.033
Sift
Uncertain
0.020
D;.;D;.;.;.
Sift4G
Benign
0.14
T;.;T;.;.;.
Polyphen
0.40
B;B;B;B;B;.
Vest4
0.12
MVP
0.54
MPC
0.088
ClinPred
0.0050
T
GERP RS
2.8
PromoterAI
0.0064
Neutral
Varity_R
0.12
gMVP
0.10
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs367767249; hg19: chrX-48681941; COSMIC: COSV61930587; COSMIC: COSV61930587; API